GlycoMimetics
GLYC
#10327
Rank
NZ$17.59 M
Marketcap
NZ$0.27
Share price
-5.42%
Change (1 day)
-44.71%
Change (1 year)

GlycoMimetics (GLYC) - Net assets

Net assets on the balance sheet as of March 2025 : NZ$5.86 Million

According to GlycoMimetics 's latest financial reports the company has NZ$5.86 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

GlycoMimetics - Net assets on balance sheet (from 2012 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$9.42 M-84.49%
2023-12-31$NZ$60.74 M-10.16%
2022-12-31$NZ$67.61 M-43.4%
2021-12-31$NZ$0.11 B-32.77%
2020-12-31$NZ$0.17 B-22.39%
2019-12-31$NZ$0.22 B-25.25%
2018-12-31$NZ$0.30 B81.74%
2017-12-31$NZ$0.16 B230.72%
2016-12-31$NZ$50.96 M-13.82%
2015-12-31$NZ$59.13 M-8.8%
2014-12-31$NZ$64.84 M1732.67%
2013-12-31$NZ$3.53 M-76.77%
2012-12-31$NZ$15.22 M40.55%
2011-12-31$NZ$10.83 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
bluebird bio
BLUE
-NZ$0.11 Billion-1,814.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$161.63 B 2,758,095.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$149.82 B 2,556,664.68%๐Ÿ‡ซ๐Ÿ‡ท France
Johnson & Johnson
JNJ
NZ$137.63 B 2,348,674.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-NZ$11.09 Million-289.23%๐Ÿ‡บ๐Ÿ‡ธ USA